SAB Biotherapeutics, Inc. Quarterly Current Ratio in % from Q3 2021 to Q2 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: SAB Biotherapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q2 2024.
SAB Biotherapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 414 %, a 244% increase year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	414	+294	+244%	Jun 30, 2024
Q1 2024	300	+159	+113%	Mar 31, 2024
Q4 2023	193	+31	+19.2%	Dec 31, 2023
Q3 2023	101	-72.9	-42%	Sep 30, 2023
Q2 2023	120	-65.7	-35.3%	Jun 30, 2023
Q1 2023	140	-52.3	-27.1%	Mar 31, 2023
Q4 2022	162	-34.7	-17.7%	Dec 31, 2022
Q3 2022	174	-147	-45.9%	Sep 30, 2022
Q2 2022	186			Jun 30, 2022
Q1 2022	193			Mar 31, 2022
Q4 2021	196			Dec 31, 2021
Q3 2021	321			Sep 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.